Full-Time

Senior Regulatory Affairs

Regulatory Affairs

ICU Medical

ICU Medical

5,001-10,000 employees

IV therapy systems and safety solutions

Compensation Overview

$97.5k - $139.8k/yr

+ Annual Incentive Plan

Highland Park, IL, USA

Hybrid

Category
Legal & Compliance
Required Skills
Pharmacology

Get referred to ICU Medical

Find people who can refer or advise you

Requirements
  • Must be at least 18 years of age
  • High School Diploma required
  • Bachelor’s degree from an accredited college in pharmacy, biology, chemistry, pharmacology, engineering or related subject or university is required
  • Master’s Degree or Ph.D preferred
  • RAC Certification preferred
  • Seven plus years of experience in Medical Products Industry in Regulatory Affairs
  • Able to lead scientific arguments and apply analytical and logical reasonings
  • Ability to effectively prioritize workload and multitask with minimal supervision
  • Good interpersonal skills
  • Good oral and written communications skills
  • Demonstrated project management skills
  • Demonstrated critical thinking, contingency planning and negotiating skills
  • Understanding of regulatory and business needs with ability to establish direction and influence cross functional team members
Responsibilities
  • Provides regulatory advice and support to assigned products/teams.
  • Identifies and communicates registration needs and strategies.
  • Maintains awareness of applicable regulations.
  • Plans and organizes registration packages for device products.
  • Prepares registration packages in line with local regulatory requirements and guidelines.
  • With oversight, serves as a liaison with regulatory agencies pertaining to assigned products.
  • Assists in the preparation of agency meeting packages and strategies for agency meetings.
  • Evaluates manufacturing and labeling changes for regulatory impact.
  • Accurately describes these changes for ease of regulatory agency review.
  • Work with region and country regulatory affairs counterparts to evaluate changes for regulatory impact and to ensure compliance with applicable regulations.
  • Accurately describes these changes for ease of regulatory agency review.
  • Represents Global Regulatory Affairs at research and development meetings and presents agreed upon regulatory positions.
  • May serve as a lead regulatory representative to an assigned product or project team.
Desired Qualifications
  • None

ICU Medical focuses exclusively on IV therapy across the care continuum. It develops and supplies IV therapy systems, software, and consumables designed to fit existing clinical workflows and improve patient safety and experience. Its product line includes dedicated and non-dedicated IV sets and needle-free connectors that reduce bacterial transfer, a broad range of IV smart pumps for large-volume, pain-management, and ambulatory use, and IV medication safety software that interoperates with IV-EHR systems to support safer, more efficient care. The company differentiates itself by being 100% focused on IV therapy (a result of acquiring Hospira Infusion Systems) with extensive manufacturing and supply capabilities and the broadest IV pump portfolio, enabling strong compatibility with many EHR systems. ICU Medical’s goal is to improve the safety and efficiency of IV therapy and strengthen the clinical experience for patients and caregivers.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

San Clemente, California

Founded

1984

Get referred to ICU Medical

Find people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Installed-base pump refresh cycle is beginning, supporting recurring revenue.
  • Consumables segment generates $1 billion and grows 5%-7% annually.
  • Management targets leverage near 2x and share buybacks next year.

What critics are saying

  • FDA approval delays are slowing new hardware rollout and software monetization.
  • Vital Care decline and SKU exits continue to drag reported growth.
  • Tariff, logistics, and pricing-reset pressures threaten 2026 margin expansion.

What makes ICU Medical unique

  • Pure-play infusion therapy company after exiting IV Solutions in 2025.
  • Top-tier positions across consumables, infusion systems, and vital care.
  • New Plum Solo and Plum Duo pumps target precision delivery.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Company News

AVATAR Group
Apr 2nd, 2026
Paths to precision: choosing the right vascular access device.

Paths to precision: choosing the right vascular access device. Posted on 2 April 2026 Selecting the appropriate vascular access device is crucial for effective patient care and treatment outcomes... *. ICU Medical has provided grant funding to AVATAR

ICU Medical
May 15th, 2025
ICU Medical and VisionHealth Launch MyAcapella(TM) Digital OPEP Coach to Improve OPEP Therapy and Adherence for Respiratory Patients

May 15, 2025 - ICU Medical Inc. (NASDAQ:ICUI), in collaboration with VisionHealth GmbH, has announced the launch of MyAcapella, a mobile application designed to support Oscillating Positive Expiratory Pressure (OPEP) therapy for patients with chronic respiratory conditions.